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Abstract 
 
Caseous lymphadenitis (CL) is a chronic disease that affects sheep and goats 
worldwide. CL causes a large economic loss to producers via milk and fiber losses, 
carcass condemnation, and chronic wasting of animals. Corynebacterium 
pseudotuberculosis (C. psTB) causes CL, and infected animals produce abscesses, 
typically in lymph nodes, lungs, liver, and mammary tissues. Ruptured abscesses release 
C. psTB, and can contaminate the environment. The bacteria are extremely hardy and can 
survive in the external environment for over a year, infecting other animals through open 
wounds.  
 
Macrophages engulf C. psTB when it enters the body, and carry it to the lymph nodes. 
Corynebacterium pseudotuberculosis possesses some mechanisms that prevent lysis by 
the macrophages. When C. psTB reaches the lymph tissues, many immune cells attack the 
area, and this causes the abscesses. Recent studies suggest that some individual animals 
are resistant to clinical CL. To test this phenomenon, we collected blood from cattle and 
sheep, developed a protocol for macrophage culture, and produced CL antigens to 
challenge the macrophages. We tested macrophage cytokine (IL10) response to 
stimulation with antigens using a commercial Enzyme Linked Immunosorbent Assay 
(ELISA). There was no measureable IL10 response detected. Future work will evaluate 
other cytokines (IL8) and will investigate genetic (NOD2) resistance to CL. 
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 1 
Introduction 
 
Sheep producers have a substantial impact on the farm economy, but factors like 
predation and disease seriously affect their business. In the United States, there are over 
5.2 million sheep. The gross income from the sheep industry in the United Sates is 5.5 
million dollars per year. In New England (Maine, Massachusetts, Vermont, New 
Hampshire, Rhode Island, and Connecticut) alone, there are 43,000 sheep and lambs.1 
In 2009, 387,300 sheep and lambs lost in the United States (61% of total losses) were 
due to non-predatory factors, and of these, almost 30% were disease-related.2 These 
losses cause an economic impact on the producers who raise sheep in the United States. 
In 2003, a report from Australia claimed that caseous lymphadenitis (CL) causes a 4-7% 
decrease in clean wool production per sheep, per year.3 Along with carcass condemnation 
due to abscesses, this disease causes a significant impact to small ruminant producers. If a 
farmer had 200 sheep with CL, and they lost 5% of wool production and 10% of 
carcasses, they would lose close to $500 per year. This is potentially a bigger factor with 
chronic diseases, like CL, which cause economic losses year after year because 
chronically infected animals remain part of the flock.  
Caseous lymphadenitis is a chronic disease caused by Corynebacterium 
pseudotuberculosis (C. psTB) that affects a number of species, including small ruminants. 
Caseous lymphadenitis causes internal and external abscesses, typically of the lymph 
nodes, but also of internal organs, including the liver, mammary tissue, and lungs. Once 
this disease affects one animal in the flock, it is nearly impossible to remove from the 
flock. Most farms ‘manage’ a flock with CL, rather than eradicate the disease.4 There are 
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two main methods of handling flocks with CL. The first is the “Test and Cull” method. In 
this program, farmers test all of the animals in their flock or herd, and cull any that come 
up positive for the CL antibodies. The farmer waits two months, and tests all of the 
animals again, and culls any positive. This continues until the farmer no longer has any 
animals that are positive for CL antibodies. This method is an effective way to rid a farm 
of CL, but it is difficult to maintain flock size, let alone grow a flock, and it also can cost 
the producer a lot of money in lost products.5  
The second management strategy is to keep two separate flocks. One flock is CL-
positive animals, and one flock is CL-negative animals. If a farmer has animals they do 
not want to cull, this method can be effective. The downfall with this is that it is 
expensive because the two flocks must have completely separate land, shelters, feeders, 
and equipment, and there cannot be any overlap. It is also inconvenient to take care of 
two distinct flocks, and a farmer must always work with the CL-negative flock first, and 
then move to the CL-positive flock. Over time, it is possible to remove CL from a farm 
using this manner. Any lambs that are born in the CL-positive flock need to be pulled 
immediately and hand-reared or adopted to an animal in the CL-negative flock. 
Eventually, the animals in the CL-positive flock will be removed by natural attrition 
(natural death or culling due to reduced productivity), and the farmer will be left with a 
CL free farm. Both of these management strategies have disadvantages, but keeping 
infected animals in contact with non-infected animals will cause a continual economic 
loss to the producer.6 
Caseous lymphadenitis is most frequently characterized by the formation of external 
abscesses on the superficial lymph nodes of the animals. The disease does not always 
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present visible abscesses, and because of this, it is difficult to detect the prevalence of 
CL.7 In 2003, a study in Australia found that 26% of sampled farms had animals with 
CL.8 There has been an estimated prevalence of up to 43% in the United States.9 This 
disease presents not only an economic challenge, but because CL is also a zoonotic 
disease, which means it poses a threat for humans who work with infected animals, it can 
become a public health challenge.10 
How is CL spread? The bacteria’s main path of entry into the host is through a cut or 
abrasion in the skin. Shearing equipment often acts as a tool for passing the bacteria from 
one animal to another. CL causes abscesses in the lymph nodes and some internal organs. 
When a CL abscess bursts, a “cheesy” (caseous) pus, containing millions of C. psTB, is 
released, and can survive in the external environment and infect other animals for 
months. Thus, CL is a persistent threat once established on a farm. 
Once in the host, how does CL cause damage? The bacteria are ill equipped to set up 
an infection at the site of entry, so most often, the abscesses do not appear at the site of 
the external wound. Instead, a macrophage phagocytizes the bacterium, and carries it to 
the lymph nodes. Normally, invading bacteria are killed in the macrophage by the 
lysosome. However, because these bacteria are facultative intracellular pathogens, they 
can survive in the macrophage for up to 48 hours.11 The bacteria contain an external lipid 
layer of the cell wall, which allows them to survive the action of phagolysosome 
enzymes.12 Corynebacterium pseudotuberculosis produces phospholipase D (PLD), an 
exotoxin that has been identified as the primary virulence factor of the bacteria. Most 
researchers agree that the PLD is what is responsible for the ability of the bacteria to lyse 
macrophages, and gain access to the lymph nodes.13 
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When the bacteria infect the lymph nodes, many macrophages and lymphocytes rush 
to the site of infection. These cells, led by macrophages, induce a thick wall of fibroblasts 
and macrophages around the infection, creating a pyogranuloma.14 The external abscesses 
may also include signs such as swelling and loss of hair at the area.15 Abscesses are the 
primary sign of CL infection, and may be internal, so unseen by the farmer until 
slaughter. 
Host immune defenses are critical to avoiding CL. The immune system is broken into 
innate and adaptive immunity. Innate immunity is non-specific, and acts as a defense 
against any foreign body trying to enter the system. Adaptive immunity is responsible for 
fighting against specific pathogens. Macrophages are considered cells in the category of 
innate immunity, but they also act as the bridge between innate and adaptive immunity. 
These cells phagocytize and digest foreign particles, which make them non-specific (like 
the innate immune system), but they present antigens so that lymphocytes can create 
antibodies, which then triggers the adaptive immune system. Macrophages also link the 
innate and adaptive immune processes, by eliciting cytokine responses. Cytokines are 
small proteins that act as “cell signals” in response to stimuli. Macrophages can 
communicate to other macrophages, as well as with different cells using cytokines.16 
Usually when a macrophage encounters a bacterium such as C. psTB, the macrophage 
engulfs the bacterium, and immediately floods the bacteria with oxygen radicals and acid 
in attempts to kill the cell.17 However, C. psTB can survive in the macrophages, and they 
are carried to the lymph nodes inside the macrophages.18 
The fact that C. psTB transits to the lymph nodes in macrophages suggests a possible 
deficiency of macrophage function in animals with CL. Pépin et al. (1997) performed an 
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experiment on lambs to evaluate cytokine release after infection with C. psTB. The 
researchers inoculated the lambs with one of the following: C. psTB PLD toxin, a strain 
of C. psTB lacking the PLD gene, a wild-type strain of C. psTB, or a control. After 7 or 
28 days, they completed necropsies on the lambs, sampled the lymph nodes and lungs, 
and performed polymerase chain reaction (PCR) on each sample, looking for production 
of specific cytokines, including IL2, IL4, IL6, IL8, TNFα, and IFNγ. The study 
concluded that there was a large amount of variability in the results, probably due to 
individual variations among lambs. Interferon-γ appeared to be the most relevant 
cytokine, as there was significant production of interferon- γ in all of the sheep infected 
with any strain of the C. psTB bacteria.19 
Recently, scientists have been using this information to try to create a simpler 
diagnostic test for CL. Rebouças et al. (2011) collected peripheral blood leukocytes from 
animals who tested seropositive for CL and animals who tested seronegative for CL. 
Seropositive animals produced a higher amount of interferon-γ than seronegative 
animals. They concluded this could be used a potential marker for animals with CL, 
although the ELISA they created had a low sensitivity (55.8% and 56% in sheep and 
goats, respectively), and the researchers suggested this value should be higher before this 
is a complete diagnostic tool.20 Corynebacterium pseudotuberculosis is not the only 
pathogen or condition that elicits release of IFNγ. This ELISA would most likely have 
many false positives because of this fact. 
Bastos et al. (2011) also outlined a possible diagnostic marker for CL. This study 
focused on measuring the concentration of haptoglobin (a protein that binds to free 
hemoglobin in the blood) and the total leukocyte count. The researchers concluded that 
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the amount of haptoglobin and total leukocytes are not reliable markers for diagnosing 
CL, however, the number of monocytes may be a consistent measurable value to 
determine if an animals has CL.21 As of right now, the most reliable test is the Synergistic 
Hemolytic Inhibition (SHI) test. Only a few laboratories in the nation complete this test. 
A culture plate is created using 7% bovine blood and Rhodococcus equi toxin. 
Corynebacterium pseudotuberculosis and R. equi will experience synergistic hemolysis 
(or breaking down of red blood cells) when allowed to interact with one another. The SHI 
test uses this fact to determine whether an animal has been exposed to CL or not. A blood 
sample is taken from the animal, and sera is collected. On a small paper disk, CL toxin 
and the sera are mixed. If the animal has been exposed to CL, their sera with contain CL 
antibodies, the two toxins will not interact, and there will be no zone of clearing around 
the disk. If an animal has never been exposed to CL, the two toxins will interact, and 
there will be a zone of clearing around the disk.22 
Interferon-γ can activate ovine pulmonary alveolar macrophages (PAM), along with 
having many other functions. A second study investigated the roles of interferon-γ, tumor 
necrosis factor α, and interleukin 1 levels in response to C. psTB in vitro using 
macrophages collected post-mortem. Based on previous studies, the researchers 
investigated whether cytokine production had an effect on the replication of C. psTB. 
This study found that recombinant cytokines had no stimulatory or inhibitory effect on 
the growth of the bacteria in an acellular system, however, the PAM significantly reduce 
the growth of C. psTB. When the PAM were pretreated with cytokine, either one cytokine 
at a time, or as combinations of more than one cytokine, there was no increase in 
intracellular killing. Although macrophages reduced growth by phagocytizing these 
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bacteria, macrophages were not effective at killing C. psTB once it was phagocytized. 
This study did not report whether the macrophages were destroyed or intact following 
infection with bacteria.23 This study suggests that these three cytokines (IFNγ, TNFα, and 
IL1) do not have a stimulatory effect on the macrophages to enhance kill of C. psTB. 
Although cytokine enhancement of CL-infected macrophage activity has been 
investigated, cytokine suppression of macrophage activity may be a factor in CL 
intracellular survival. These studies discussed demonstrate the need for further 
investigation of how C. psTB interacts with macrophages, and why the macrophages do 
not kill the bacteria upon phagocytosis. 
Interleukin 10 (IL10) is a cytokine responsible for suppression of monocyte, 
macrophage, T cell, and natural killer cell function. Specifically, IL10 inhibits the 
transcription of other cytokines that these cells produce. Monocytes are the predominant 
producers of IL10.24 For this reason, we chose to investigate if monocytes and 
macrophages of animals that are CL-positive produce a different amount of IL10 than 
cells of CL-negative animals. 
The overall objective of this project is to investigate cytokines produced by CL-
positive sheep’s macrophages, versus CL-negative sheep’s macrophages. The objectives 
of this experiment were to develop procedures and techniques, such as effective blood 
draw and collection skills, macrophage cell culturing methods, and proper use of an 
Enzyme-Linked Immunosorbant Assay (ELISA) for investigation of macrophage 
cytokine production. 
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MATERIALS AND METHODS 
 
Many small preliminary experiments were completed during this project. The first 
experiment included drawing blood from seven sheep on a farm in Maine. Ten milliliters 
of blood was drawn from the jugular vein of the animals into purple-topped vacutainers, 
which contain the anticoagulant ethylenediamine tetraacetic acid (EDTA). This farm had 
been previously tested, and was known to have CL-positive animals. Blood was drawn 
from four older ewes (3+ years) that had repeatedly tested negative for CL antigens, one 
female lamb (3 months old), whose CL status was unknown, and two CL+ rams. The 
blood was processed in an initial attempt to isolate macrophages. A 2:1 solution was 
made of Hank’s Balanced Salt Solution (HBSS) (Fisher Scientific, SH 3001602) and the 
10mL of blood from each sheep. The mixture was then gently pipetted on top of a Ficoll 
Paque (Fisher, 45-001-751) layer, and centrifuged to create layers of separation. The 
layer just above the pellet of red blood cells that was thought to be the peripheral blood 
mononuclear cells (PBMCs) was carefully pipetted off the Ficoll layer, using sterile 
technique, and placed in a centrifuge tube with HBSS. The cells were washed using 
gentle centrifugation (900xg for 30 minutes), and they were then resuspended in Roswell 
Park Memorial Institute media with L-glutamine (RPMI) (Fisher, SH3002701) with 
penicillin and streptomycin (pen/strep) (Fisher, BP295950), and 10% heat inactivated 
fetal bovine serum (FBS) (Fisher, SH3091002HI). The suspension was then divided into 
6 aliquots, and each was pipetted into a row of a 48-well plate. The plate was incubated 
in a 35°C incubator at 5% CO2. During the incubation period, the cells were visually 
inspected using an Olympus CKX41 inverted microscope. Changes in the density of 
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cells, color of media, shape of cells, amount of contamination, and any other changes 
were recorded. The media of these wells was freshened approximately every 7 days. The 
old media was gently pipetted out of the wells and disposed of. One mL of HBSS was 
added to each well, and the plate was rocked gently by hand for 1 minute to rinse the 
cells. The HBSS was pipetted out of the wells, 1 mL of fresh supplemented RPMI was 
placed back into the wells, and the plate was placed back in the CO2 incubator. 
One month after processing this round of blood, the viability of the cultured cells was 
determined. The cells were dislodged from their adherence to the plate by adding 0.05% 
trypsin (Fisher, MT-25-051-CI). The cells were suspended in trypsin for 20 minutes, and 
then a 50µL aliquot was taken from a well and added to a 1.5mL cryogenic tube, which 
contained 175µL of supplemented RPMI and 25µL of 0.4% trypan blue (Fisher, MT-25-
900-Cl). This solution was mixed by gentle inversion of the tube, and 10µL were pipetted 
onto the surface of a hemocytometer. A cover slip was applied, the number of cells in the 
central grid was counted, and the cell concentration and viability was calculated based on 
the area of the central grid (See Table 1). The cell count/mL was calculated using the Cell 
Counting SOP. To find cells/mL blood, the number of cells seen in central grid was 
multiplied by 104, which is the hemocytometer factor, and by the dilution factor. The 
number of viable cells was determined using trypan blue, an impermeable dye. Live cells 
will not take up this dye, but dead cells are permeable to it, and become stained blue.25 
Each cell in the grid is counted, and the percent of viable cells is figured out by dividing 
the number of unstained cells by the total number of cells in the grid.  
In order to preserve these cell samples, a cell freezing technique was produced. The 
cells were incubated in 1mL of 0.05% trypsin to remove them from the cell culture plate. 
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The cells were placed in a 1.5mL cryogenic vial once they were no longer adherent to the 
plate. The samples were centrifuged and the supernatant was removed. The pellets were 
suspended in freezing media (RPMI with dimethyl sulfoxide; DMSO (Fisher, MT-25-
950-CQC)). Once resuspended, the cells were placed in a -20°C freezer for one hour, and 
then transferred to an -80°C freezer for storage. 
The next experiment involved taking blood from heifers at the J. F. Witter Teaching 
and Research Center. Approximately 250mL of blood was drawn from the jugular vein of 
three 1-year-old heifers. Blood was collected in a collection bag that contained the 
anticoagulant, citrate phosphate dextrose adenine (CPDA). While blood was being 
collected, the bag was agitated to ensure mixing of blood with the anticoagulant.  
Once the blood was collected, it was processed in a similar procedure to the first cell 
collection trial. In this trial, the layer between the Ficoll and plasma layers was collected, 
which is the layer that truly contained PBMC. Instead of being cultured in a 48-well 
plate, the cells were now cultured in 6 different 75cm2 Cell Culture Flasks. In this trial, 
the seeding density was measured, using the previously described cell counting 
technique. 20µL of blood was mixed with 380µL of glacial acetic acid. 10µL of this 
solution was placed onto each side of a hemocytometer and the number of cells in the 
central grids was counted, then averaged. See the results for the number of WBC. The 
flasks were visualized using an Olympus CKX41 inverted light microscope.  
The next few techniques were completed to prepare for using the IL10 ELISA. 
One colony of C. psTB was collected from a plate culture using a sterile stab, and was 
used to inoculate a 5mL glass tube of Brain Heart Infusion (BHI) broth. In addition, gram 
stains were performed on the culture to ensure that only C. psTB was collected. A single 
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colony was collected using a sterile stab and was heat-killed over a flame and placed on a 
microscope slide. On a second slide, bacteria collected on a stab that ran over an area of 
confluent growth were also prepared. Crystal violet stain was added for 1 minute and 
rinsed off with tap water. Gram’s iodine was added for 1 minute, and was removed by 
tipping the slide. The bacteria was decolorized with ethanol for a few seconds, and then 
rinsed with tap water. Safranin was added for 1 minute, and rinsed with tap water. The 
slides were allowed to fully dry before being inspected under a light microscope.  
The method to heat-kill C. psTB was determined next. A new BHI broth culture was 
set up in a 50mL centrifuge tube in the same way as before using the plate C. psTB 
ATCC 19410FD. Ten labeled 1.5mL cryogenic tubes were inoculated with a single 
colony from the plate. There were five treatments: treatment 1 was incubated at room 
temperature (control); treatment 2 was 70°C for 5 minutes; treatment 3 was 70°C for 10 
minutes; treatment 4 was 100°C for 5 minute; treatment 5 was 100°C for 10 minute. Each 
treatment was completed in duplicate. The bacteria from these vials were placed on a 
blood agar plate and incubated at 37°C for 48 hours, and the results were recorded. 
Blood was collected again from a heifer at Witter Farm, and processed in the same 
manner as before. One sample was incubated in a 75cm2 flask, and the second sample 
was incubated in a 48-well plate. The cells were counted to obtain an amount of cells/mL 
of blood. See the results for this information. The cells were visualized 1 week later. 
Using Corning’s “Surface Areas and Recommended Media Volumes for Corning Cell 
Culture Vessels”, the correct density was determined to be around 106 cells/cm2. The 
density of the flask and wells were determined (see results). 
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To urge the monocytes in the wells to differentiate, the density was reduced by 
replating the monocytes in another well. The chosen wells were scraped using a pipette 
tip, and 20µL of scraped cells were placed into a well of a 24-well plate that contained 
2980µL of supplemented RPMI. 
Again, bovine blood was collected at Witter Farm, and the seeding density was 
determined for a 24-well plate. These macrophages were used for the first IL10 ELISA 
trial. The first ELISA trial consisted of challenging macrophages for the same amount of 
time with three different C. psTB antigens. The first antigen was live C. psTB. To prepare 
this, a suspension was created in 6mL of RPMI by adding colonies of C. psTB until the 
spectrophotometer read 80% transmittance at 590nm. One mL each of this solution was 
placed into two 1.5mL centrifuge tubes.  
At the same time, a mini experiment to determine how many colony forming units 
(CFU) were in 1mL of the suspension was taking place. Ten µL of the suspension was 
pipetted into 990µL of BHI and plated. This made a 1:100 dilution. Ten µL of the 1:100 
dilution were pipetted into 990µL BHI to create a 1:10,000 dilution. Finally, 10µL of that 
were placed into 990µL of BHI to create a 1:100,00 dilution. Ten µL of the 1:100,000 
dilution was plated out onto three Blood Agar Plates, and one plate had 10µL of the 
1:10,000 dilution on it. The results of this mini experiment are located in the results 
section.  
The second antigen prepared was C. psTB toxin. Five µL of concentrated C. psTB 
toxin was added to 95µL of RPMI. Ten µL of that was added to 990µL of RPMI two 
times to create dilutions of 1:20, and two tubes that contained a 1:2,000 dilution. These 
two tubes were used in the trial. The third antigen is the heat-killed C. psTB. The vials 
 13 
from the heat treatment experiment were stored in a -80°C freezer, and were retrieved for 
this preparation. The cells were thawed at room temperature, centrifuged, and the media 
was aspirated and replaced with supplemented RPMI.  
To prepare the macrophages, the wells that would be tested had the media aspirated 
out, and replaced with RPMI with FBS without penicillin or streptomycin. Wells A1 and 
A2 were challenged with 1mL of live C. psTB in RPMI at an 80% transmittance; B1 and 
B2 were challenged with 1mL of dead C. psTB in RPMI at 81% transmittance; C1 and 
C2 were challenged with 1mL of 1:2,000 C. psTB toxin in RPMI; D1 and D2 was the 
control, and the media was replaced with RPMI with FBS and no penicillin or 
streptomycin. The wells were incubated for 2 hours at 37°C in 5% CO2. After the 
incubation period, 0.5mL of supernatant was aliquoted from each treated well into a 
1.5mL centrifuge tube, and stored at 4°C overnight. The cells were placed back in the 
incubator.  
The first ELISA trial was run using the Bovine IL10 Assay Kit (#BI0030, 96 tests 
from NeoBioLabs, Park Woburn, MA) per kit instructions. A wash solution was created 
by adding 3mL of 100x wash to 297mL of sterile Deionized water at room temperature. 
The 50µL samples were placed in 0.2 mL PCR tubes in duplicate. As a control, 50µL of 
the media was placed in a tube and 50µL of A2 at 15 hours after incubation was added. 
Then 5µL of balance solution was added to each sample and 50µL of samples and 
standards were placed in 32 wells on the plate (see map in results). The assay was 
incubated covered at room temperature for 1 hour. One hundred µL of conjugate solution 
was added to each well and it was incubated for another hour in a 37°C incubator. Wells 
were washed five times with the kit-provided wash solution, and 50µL of solution A was 
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added, followed by 50µL of solution B. The assay was incubated for another 30 minutes, 
and 50µL of STOP was added. The plate was read by a plate reader at 450nm.  
For the second IL10 ELISA, blood was collected from Icelandic Ewes at Witter 
Farm. The blood was processed and macrophages were isolated. The second IL10 ELISA 
trial tested macrophages challenged with live C. psTB with samples taken at different 
time points. The solution of live C. psTB was created as before, and macrophages were 
challenged with the bacteria for 1 hour. After the wells had RPMI with penicillin and 
streptomycin placed in them, they were incubated for another hour. At 1 hour, a sample 
was taken from the four wells (2 challenge wells and 2 control wells). Samples were also 
taken at time 2, 4, 6, 12, and 24 hours. The ELISA assay was run using these 24 samples 
in duplicate.  
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RESULTS AND DISCUSSION 
 
The first trial of processing blood collected from sheep at a farm in Maine was 
unsuccessful for a few reasons. First, the centrifugation used was too aggressive, and 
made it impossible to recover cells. Second, the layer that was pulled off when the 
sample was processed with Ficoll Paque was the layer that contained granulocytes, not 
PBMC. The figure below shows the layers that the sample separates into after 
centrifugation.   
 
Fig. 1: Ficoll paque layers after centrifugation.  The peripheral blood mononuclear cell 
(PBMC) layer contains the monocytes. The bottom layer (RBCs) is a red blood cell pellet 
(Photo: nature.com). 
 
When the viability was tested for the four samples, no viable cells were seen. Sample 
1 and 2 contained no cells, sample 3 contained 1 non-viable cell, and sample 4 had no 
cells in the grid area.  
The next blood draws were completed on bovine subjects rather than ovine subjects 
because the researchers did not have access to ovine subjects at that time. Caseous 
lymphadenitis is a disease that can also affect cattle, so the immune systems of the two 
animals are similar. In the first cell counting trial that was completed, 37 cells were 
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counted in the grid; adjusted by the dilution factors of 104 and 20, the final concentration 
was 7.4 cells/mL blood. To find the seeding densities of the 6 flasks, the original volume 
of blood that was used to create the sample in the flask was divided by the amount of 
RPMI and multiplied by the cell/mL. See the table below for the seeding densities of the 
6 flasks. 
 
Table 1: Seeding densities of 6 flasks in trial 2 of processing macrophages. 
 
Flask Number Original 
Volume of 
Blood (mL) 
Volume of 
RPMI (mL) 
Cell/mL Seeding 
Density 
(cells/mL) 
1 **** **** 7.4x106 **** 
2 33 30 7.4x106 8.14x106 
3 33 30 7.4x106 8.14x106 
4 50 30 7.4x106 1.23x107 
5 50 30 7.4x106 1.23x107 
6 50 15 7.4x106 2.47x107 
 
From a visual check, flask 6 has the most differentiation. Below is a picture of flask 6 
taken 14 days after incubation began. 
 
Fig. 2: Flask 6 - Differentiating monocytes at day 14 of incubation (Photo: Ann 
Bryant). 
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Below is a table that describes the results of the heat-kill trial.  Although not included 
in this table,  sterile BHI (without C. psTB; control) showed no growth.  
Table 2: C. psTB growth results of heat-kill trial. 
Treatment Number Sample 1 Sample 2 (Duplicate of 
Sample 1) 
1: Incubated at room temp Good Growth - Lawn Good Growth – Lawn 
2: 70°C for 5 min No Growth No Growth 
3: 70°C for 10 min No Growth No Growth 
4: 100°C for 5 min No Growth No Growth 
5: 100°C for 10 min No Growth No Growth 
 
For the third macrophage processing trial, the samples were placed in a 48-well plate 
and a 75cm2 flask. Each well contained an original volume of 3.47mL of whole blood. 
The cell count was 64 cells in the grid, which was equivalent to 1.066x107 cells/well. In 
the flask, the cell count was 36, equivalent to 1.08x108 cells/flask. The total number of 
cells/cm2 was 1.12x107 cells/cm2. In the cell culture flask there were 1.44x106 cells/cm2. 
The recommendation from Corning is that cell culture surfaces be seeded at a density 
of 106 cells/cm2. For this reason, the cells in the flask differentiated well, but the cells in 
the wells were too crowded. Below are pictures of the well and the flask. 
 
Fig. 3: Macrophages in well at 40x magnification. The seeding density is too high for the 
monocytes to differentiate into macrophages (Photo: Ann Bryant). 
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Fig. 4: Macrophages in Flask at 20x magnification. Differentiated macrophages. The 
seeding density was low enough so that there was space between the cells so the 
monocytes could differentiate (Photo: Ann Bryant). 
 
 
Because of the high density in the wells, the decision was made to replate the cells in 
new wells to decrease the cell density in the old well, and also place a correct cell density 
in new wells. The cell density was determined in two of the original wells, A1 and B1. 
The cell density in A1 was 1.30x106 cells/mL, and the cell density in B1 is 1.33x 106 
cells/mL. When 20µL was taken from each well and placed in a new well, the seeding 
density was 3.25x105. 
In the next processing of macrophages, the cell densities were determined to be 
1.0x107 cells/mL. To make 2 plates, 12mL of sample was used on each plate. 1.0x107 
cells/mL x 12mL = 1.2x108 cells total / 24 wells = 5x106 cells/well 
5x106 cells/well / 1.9cm2/well = 2.6x106 cells/cm2 
The CFUs were calculated from the 4 blood agar plates, see Table 3. 
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Table 3: Results of growing C. psTB on a blood agar plate 
Plate Number Dilution Number of Colonies 
1 1:100,000 5 
2 1:100,000 24 
3 1:100,000 3 
4 1:10,000 54 
 
The average number of colonies (1:1000 dilution) was 10.7. This was multiplied by the 
dilution factor of 105 to get 1.1x106, which is the approximate number of C.psTB CFU in 
10µL. That means there are approximately 1.1x108 CFU /mL. 
The standard curve for the first ELISA trial is shown below in Figure 5.  
 
Fig. 5: Standard curve for ELISA Trial 1 (points are mean ± SD). The graph shows the 
absorbance of the kit standards, which contained 50, 100, 250, 500, and 1000 pg/mL of 
IL-10. The error bars show the standard deviation between the duplicate samples. The R2 
value is relatively low for this curve, meaning that the points do not fall close to the line 
of best fit. This error was attributed to procedural error in the technique. 
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Figure 6 shows the data that was collected from the first ELISA trial.  
 
 
Fig. 6: Absorbance of IL10 for macrophages challenged with different antigens. The 
error bars represent the standard deviation between the duplicate samples. 
 
In the second ELISA trial, the standard curve appeared linear, with smaller standard 
deviations, see Figure 7. The samples produced very little IL10, see Figure 8. 
 
Fig. 7: Standard Curve for ELISA trial 2. The graph shows the absorbance of the kit 
standards. The standards were 50, 100, 250, 500, and 1000 pg/mL of IL-10. The error 
bars show the standard deviation between the duplicate samples. 
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Fig. 8: Absorbance at each tested time point. A2 and A3 represents wells that were 
challenged with live C. psTB, and B3 and C1 represent the control wells. The error bars 
show the standard deviation between the duplicate samples. 
 
If Figures 7 and 8 are compared, the absorbance of the highest point in Trial 2 is 
about 1/10 of the smallest standard value, which is 50pg/mL. This means that the highest 
amount of IL10 produced was about 5pg/mL, which is a very small value. The standard 
deviation of the points show that the variability within sample duplicates is greater than 
that between samples, so no conclusions can be drawn about IL10 production over time. 
However, the standard curve appeared to have provided acceptable results. 
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CONCLUSIONS AND IMPLICATIONS 
 
Throughout the process, many techniques were successful, including the macrophage 
culturing, cell counting, cell freezing, and the heat-kill treatment of C. psTB. No 
significant amount of IL10 was produced in either ELISA test. In the first ELISA trial, 
the standard curve was not linear. The R-squared value associated with the line of best fit 
is 0.93; a value closer to 1 would be desireable. Because this was the first time we used 
this IL10 kit, we had not optimized our use of the procedure. The experimental results 
revealed very little, if any, IL10 production. The duplicate samples were highly variable, 
suggesting that the IL10 levels detected may have occurred by chance. 
The second ELISA trial had a more linear standard curve, showing the improved 
technique between the two trials. Again, there is no pattern between the time points of a 
sample, and the amount of IL10 measured is very low.  
There are many variables that deserve exploration to optimize technique for 
investigating the question. We may have selected inadequate levels of antigen to 
stimulate the macrophages, or have use inadequate time for stimulation of the 
macrophages. If the antigen was in for too long, it could have killed the macrophages, 
and if the antigen was not in long enough, IL10 production might have been inadequately 
stimulated. Another source of error could have been in the time chosen to take samples. If 
IL10 was produced in the first half an hour, and then broke down in solution, the intervals 
would have all been too long. However, Le et al. (1997) concluded that the half-life for 
IL10 mRNA was 60 minutes.26 In this situation, there should have been a peak in IL10 
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production, and then the level should have dropped in a linear fashion over time until it 
reached the basal production level. However, our the data did not display this  pattern. 
This project began some of the necessary background research for future 
investigations of resistance to CL in sheep. Some basic information was gained about the 
release of IL10 from macrophages challenged with CL antigens, including live C. psTB, 
heat-killed C. psTB, and C. psTB toxin. The trials that were completed did not show any 
significant amount of IL10 release, so future work may involve utilizing different 
conditions to enhance IL10 production. Future projects could also include investigating 
different cytokines (IL8, in particular), and examining conditions that will produce 
measurable amounts of IL10. Investigating possible genetic markers for susceptibility or 
resistance to CL is another area for possible study. This work established useful standard 
operating procedures for cell culture and cytokine measurement, and served as a 
preliminary investigation of IL10’s role in the pathophysiology of CL. 
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APPENDIX A 
 
 
Monocyte isolation from whole blood standard operating procedure (SOP). 
 
 
Prepared by: Amy Fish  Date:  7/8/14  
 
Reviewed by: Anne Lichtenwalner Date: 7/12/2014 
 
Approved by: Anne Lichtenwalner Date: 10/06/2014 
 
The colored ink stamp indicates this is a controlled document. Absence of color 
indicates this copy is not controlled and will not receive revision updates. 
Purpose: 
 To remove contaminants from mammalian mononuclear blood cells to prepare 
them for use in cell cultures.  
Hazards: 
1. Exposure to penicillin and streptomycin for allergic personnel: wearing safety 
glasses, a mask, gloves and labcoat is recommended when working with this 
substance.  Working in groups of at least 2 people is required. 
2. Exposure to zoonotic pathogens from small ruminants 
3. Wear proper PPE for all lab work. 
Specimen: 
 Blood samples from sheep, cattle or goats. 
Material Required: 
• Pipettors (1 and 25 ml) and sterile tips  
• Motorized pipettor with 200 µl and 1 mL sterile pipets 
• Sterile Disposable 3ml Pasteur Pipette 
• Sharps container for tips disposal 
• 10 to 250 mL blood sample properly collected and stored in a collection tube 
containing EDTA or heparin, under refrigeration. No more than 24 hours old. 
• Per 50 ml tube of sample, 50-100 mL of sterile Hank’s Balanced Salt Solution 
(HBSS) at room temperature (SH3001602) 
• Sterile 50 ml and 15 ml tubes with tops (05-539-6) (Labnet: KD-8881-301710) 
• Tube racks for 50 and 15 ml tubes 
• Per sample, at least 10 mL sterile Ficoll-Paque solution at room temperature (45-
001-751) 
• Non-chilled centrifuge capable of 300xg and 900xg. Brake off 
• At least 100 mL per flask or well-plate of RPMI-1640 w/ L-glutamine at room 
temperature (SH3002701) 
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• 10% Heat inactivated Fetal Bovine Serum at room temperature (SH3091002HI); 
at least 5 ml per 50 ml RPMI (see chart below) 
• At least 1 mL/assay of Penicillin/Streptomycin mixture at room 
temperature(BP295950) (1000 U/mL Penicillin and 10 mg/mL Streptomycin) (see 
chart below) 
• Cell-culture type plate: 24 to 96 well plate; Corning (size dependent on assay 
being run) 
 
Procedure: 
1. Create a 1:2 mixture of whole blood to HBSS in a sterile flask. 
2. Mix gently together by swirling. 
3. Using a pipette, place 10 ml Ficoll-Paque into a new 50 mL centrifuge tube. 
4. Critical step: Gently pipette (layer) 25 ml of the 1:2 mixture of blood and HBSS 
on top of the Ficoll-Paque. Do not allow blood mixture to dispense into Ficoll-
Paque. 
NOTE: If blood is pipetted onto the Ficoll-Paque and allowed to sit for more than 
approximately 10 minutes, the interface will break down, and blood will mix into 
Ficoll-Paque layer. 
5. Turn off the brake completely (set to 0) prior to running centrifuge.  Centrifuge 
the tube at 900xg for 30 minutes at room temp. Be sure to carefully check the 
balance to avoid vibrations.  Transfer the tubes gently to the working area; avoid 
disruption of the layers. 
6. Carefully, using a sterile Pasteur pipette, remove the layer of mononuclear cells 
from the HBSS-Ficoll-Paque interface. This step may be done within a cell 
culture hood. Place half the cells into one labeled 50 ml centrifuge tube containing 
15 ml HBSS, and place the remaining half into another labeled 50 ml tube. 
NOTE: The PBMC’s are located between the top two layers. The serum is the 
orange layer on top, the Ficoll is the cloudy layer below that. There is a very thin 
clear layer with visible cells between the two. Pipette off the cells. 
7. Repeat step 3-6 twice more for a total of 3 times. 
8. Centrifuge the two tubes 300xg for 10 minutes with the brake turned off, then 
pipette off supernatant. 
9. Add 25 ml HBSS to rinse the cells. Draw cells into solution with a Pasteur 
pipette. 
10. Repeat step 7-9 for a total of three rinses. After centrifuging the third time, do not 
add HBSS, move onto step 10. 
11. Create the supplement RPMI-1640 by adding 10% heat inactivated fetal bovine 
serum and the penicillin/streptomycin mixture (see Table 2 for proportions). 
12. Resuspend the washed cells after HBSS removed, using 10 mL of the 
supplemented RPMI-1640.  Invert gently to mix. 
13. Count cell density using a hemocytometer. Adjust density to 1x105 cells/mL using 
RPMI. 
14. Divide the solution equally into each well of a 24-well plate. 
15. Bring the volume in the well up to 2.5 ml by adding in the necessary 
supplemented RPMI. 
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16. Incubate the flasks for 24 hours at 37° C in 5% CO2 in H262; check cells using 
inverted scope. 
17. Remove non-adherent cells by washing twice with room temperature HBSS. To 
do this, using sterile technique, pipette out the media without touching the bottom 
of the well from each of the 24 wells.  Replace with 1 ml of HBSS in each well, 
gently rock them for 2 minutes. Aspirate out most of the fluid without touching 
the bottom of the well. Discard this fluid. Repeat this twice more for a total of 
three HBSS washes. Replace each well with 2.5 ml of RPMI/FBS/PenStrep per 
flask (see chart below).  Rock plate gently again, and replace into incubator.  
18. Incubate the adherent cells for 7-14 days at 37 C in supplemented RPMI-1640, 
which will allow monocytes to differentiate into macrophages. 
19. After 7 days of incubation, change the media.  
a. Using sterile technique and working in a cell culture hood, aspirate out the 
old media using sterile pipette tips. Use a 1 ml pipette tip for each well.  
b. Add 2.5 ml of room temperature supplemented RPMI to each well.  
c. Place plate back in the 37C 5% CO2 incubator. 
Procedural Notes 
Use sterile technique throughout the procedure.  Work with cells in a clean cell 
culture hood.  
Ficoll-Paque: Turns yellow in appearance when deteriorated – Do not use. 18°C-
20°C is the optimal temperature for the liquid. 
 
 
References: 
Freshney, R. (1987). Culture of animal cells: A manual of basic technique (2nd ed.). New 
York: A.R. Liss. 
Revision History: 
 
 
Table 1: Making RPMI Mixture 
Size of Plate 
Being Used 
Volume of RPMI 
Needed (mL) 
Volume of 
Penicillin/Streptomycin 
Mixture Needed (mL) 
Volume of Heat-
Inactivated FBS 
Needed (mL) 
50 ml centrifuge 
tube 
45  .45 4.5 
 
 30 
APPENDIX B 
 
 
Cell counting SOP 
 
Prepared by: Amy Fish  Date:  8/5/14  
 
Reviewed by:  Ann Bryant   Date: 8/5/14  
 
Approved by: Anne Lichtenwalner Date: 8/5/14  
 
The colored ink stamp indicates this is a controlled document. Absence of color 
indicates this copy is not controlled and will not receive revision updates. 
Purpose: 
This technique will allow researchers to correctly count how many viable cells are in a 
particular sample, so that when the cells are placed in wells, they can be seeded in their 
correct density. 
Hazards: 
1. Trypan blue may cause irritation if it comes in contact with skin. It is a known 
carcinogen. Use impervious gloves to handle.   Trypan blue is handled as a dilute 
solution in this procedure to reduce risk. 
2. Always wear proper PPE 
Specimen: 
 Any type of cell solution 
Material Required: 
• 37°C water bath 
• Supplemented RPMI (See Cell Wash SOP) 
• 1ml pipette 
• Sterile pipette tips 
• Sterile PBS 
• Hemocytometer 
• Cover Slips for Hemocytometer 
• 70% ethanol 
• KIM wipes 
• Microscope 
• Sterile 96-well plate 
Procedure: 
1. Clean the hemocytometer and cover slip using 70% ethanol and KIM wipes 
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2. Place the coverslip onto the hemocytometer 
3. Create cell stock by either thawing a sample (see cell thawing SOP) or by 
preparing a cell culture as follows: 
a. Aspirate the media from the well 
b. Rinse the cells once with 1ml of PBS 
c. Remove PBS and add 1ml of 0.05% trypsin 
d. Incubate the well at 37°C and 5% CO2 until cells appear rounded and 
floating. Check cells at 10, 20, and 30 minutes. 
4. Add 25µl of 0.4% trypan blue solution to 212.5µl of supplemented RPMI in a 
sterile 1.5 ml cryogenic snapcap tube 
5. Add 12.5µl of cell stock to the trypan blue and RPMI, and gently pipet up and 
down 4-5 times to mix the solution 
Note: These values create a 1:20 dilution 
6. Pipette out 10µl of the solution  
7. Dispense the solution onto one of the V-shaped wells on the side of the 
hemocytometer (with the coverslip in place) 
8. Pipette another 10µl onto the second side of the hemocytometer. 
9. After the hemocytometer has filled by capillary action, place the hemocytometer 
on the microscope stage 
10. Bring the image into focus on low power 
11. Count all cells (viable and non-viable) in the 1mm center square and the 4 corner 
squares 
12. Keep a separate count of viable and non-viable cells 
13. Use Corning’s “Surface Areas and Recommended Medium Volume for Corning 
Cell Culture Vessels” to determine the seeding density of the specific cell culture 
plate or flask. 
 
Procedural Notes 
              
 
References: 
http://web.mnstate.edu/provost/CountingCellsHemocytometer.pdf 
http://www.lipidmaps.org/protocols/PP0000000100.pdf
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APPENDIX C 
 
Challenging macrophages with C. psTB antigens (Trial 1) SOP  
 
Prepared by: Amy Fish   Date:  11/17/14 
 
Reviewed by: Ann Bryant   Date: 11/17/14  
 
Approved by: Anne Lichtenwalner  Date: 11/17/14  
 
The colored ink stamp indicates this is a controlled document. Absence of color 
indicates this copy is not controlled and will not receive revision updates. 
Purpose: 
How to challenge macrophages with CL toxin, live Corynebacterium pseudotuberculosis, 
and dead C. psTB. 
Hazards: 
C. psTB is a BSL 2 organism, and can cause infection in humans. Make sure that all PPE 
is on and secure. Wear a face mask in addition to gloves and lab coat.  Lab work must be 
directly supervised by laboratory technician or lab director. 
Specimen: 
 Cultured bovine or ovine macrophages 
Material Required: 
• 37°C 5% CO2 incubator 
• Cultured Macrophages 
• Live Corynebacterium pseudotuberculosis 
• Heat killed C. pseudotuberculosis (See Heat Treatment SOP) 
• C. psTB Toxin 
• Hank’s balanced salt solution (HBSS) 
• 1 ml pipettor with sterile tips 
• 1 µl pipettor with sterile tips 
• Spectrometer 
• BHI broth 
• Supplemented RPMI (without Pen/Strep) 
• Supplemented RPMI (with Pen/Strep) 
Procedure: 
1. Designate how many wells will receive each treatment. 
2. Draw this plan out in a lab notebook. 
3. Infect macrophages with whole killed bacteria 
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a. Adjust absorbance of the media plus dead cells to 40% absorbance (this 
will equate to a 106 cell/ml density) by adding BHI broth if necessary. 
b. Spin the cells down at 900xg for 10 minutes to create a pellet.  
c. Aspirate all of the BHI broth out of the microtube. 
d. Add in the same volume of Supplemented RPMI (see cell washing SOP) 
to replace the aspirated BHI. 
e. Ensure that the cells are mixed back into the RPMI by using the 
spectrometer.  
f. Aspirate out the 2ml of media in the wells that will be challenged. 
g. Add 1ml of the bacteria/RPMI mixture to each of the wells of 
macrophages designated to be challenged by killed bacteria.  
4. Infect macrophages with live bacteria. 
a. Repeat steps a-f from above.  
b. Add 1ml of the bacteria/RPMI mixture to each well designated to be 
challenged by live bacteria. 
5. Infect macrophages with C. psTB toxin. 
a. Dilute the toxin in a 1:2000 dilution. 
b. 1µl of toxin into 2000µl of supplemented RPMI 
c. Aspirate out the 2 ml of supplemented RPMI present in each well that will 
be challenged.  
d. Pipette 1 ml of toxin/RPMI mix into each well designated to be challenged 
with C. psTB toxin. 
6. Place the plate back in the incubator for 1 hour. 
7. Asprirate out the challenging media from each well. 
8. Pipette in 1 ml of supplemented RPMI (with pen/strep) 
9. Incubate plate for another 1 hour. 
10. Draw out 110µl from each well and place in a labeled snapcap vial. 
11. Run the ELISA using these samples and the kit standards. 
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APPENDIX D 
 
Challenging macrophages with live C. psTB (Trial 2) SOP 
 
 
 
Prepared by: Amy Fish  Date:  12/9/14  
 
Reviewed by: Ann Bryant   Date: 12/9/14  
 
Approved by: Anne Lichtenwalner  Date: 12/9/14 
 
The colored ink stamp indicates this is a controlled document. Absence of color 
indicates this copy is not controlled and will not receive revision updates. 
Purpose: 
Challenge macrophages with live Corynebacterium pseudotuberculosis.  
Hazards: 
C. psTB is a BSL 2 organism, and can cause infection in humans. Make sure that all PPE 
is on and secure. Wear a face mask in addition to gloves and lab coat.  All work in the lab 
must be done under the direct supervision of the lab technician or lab director. 
Specimen: 
 Cultured bovine or ovine macrophages 
Material Required: 
• 37°C 5% CO2 incubator 
• Cultured Macrophages, 14 days old 
• Live Corynebacterium pseudotuberculosis culture (from pure plated culture), 4 days 
old 
• Hank’s balanced salt solution (HBSS) (37C) 
• 1 ml pipettor with sterile tips 
• 10 µl pipettor with sterile tips 
• Spectrophotometer (Spec 20, Bausch and Lomb) 
• Sterile BHI broth 
• Supplemented sterile RPMI (without Pen/Strep) (37C) 
• Supplemented sterile RPMI (with Pen/Strep) (37C) 
• Sterile loops 
• 1.5 ml sterile cryogenic snapcap 
• IL-10 ELISA kit 
Procedure: 
12. Prepare C. pseudotuberculosis broth 
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a. Using a sterile loop, pick about 3 single colonies from the C. 
pseudotuberculosis culture plate.  
b. Stir the loop into a sterile glass tube with 6ml of RPMI with no Pen/Strep 
c. Check that the tube has 80% transmittance in the spectrophotometer, with 
RPMI as a blank. 
i. If not, adjust by adding more bacteria or RPMI as necessary. 
d. Place 1 ml of the 80% solution into a 1.5ml cryogenic snapcap tube 
e. Pipette out 10µl of the 80% solution into 990µl of BHI (creating a 1:100 
dilution). 
f. Dilute again by taking 10µl of the 1:100 dilution and placing it into 990µl 
of BHI (resulting in a 1:10,000 dilution). This is the working stock. 
i. Spread 10µl of the working stock onto 3 blood agar plates to 
determine how many CFUs are in the working stock. 
ii. Incubate the plates at 37C for 3 days. 
iii. Count the CFUs and average the three plate values together. 
13. Choose the macrophages by visually picking two wells that have approximately 
the same density, and by completing cell counts on each using the Cell Counting 
SOP. This will define average cell density. 
14. Assign treatments and map out which two wells will be used for bacteria, and 
which two will be used as the “cells in media” control.  
15. Infect macrophages with live bacteria. 
a. Aspirate out all of the RPMI w/ Pen/strep (should be 2ml) from each well 
needed  
b. Add 3 ml of C. pseudotuberculosis working stock. 
16. Incubate the cells for 1 hour at 37C in H240. 
17. Remove the C. pseudotuberculosis media from each well, and replace with 
RPMI w/ pen/strep 
18. Replace in the incubator for 1 hour 
19. Draw out 110µl from each well (both C. pseudo wells and both cell and media 
control wells) and place in a labeled snapcap vial. 
20. Replace in the incubator. 
21. Repeat steps 8-10 at hour 2 (after media change), hour 4, 6, 11, and 21.   
22. Run the ELISA using all 48 samples (plus the 14 standards).  
 
Procedural Notes 
              
** This will use up the remaining ELISA wells, and we will need to buy another 
before we can test anything else. We believe it is necessary to collect data from so 
many time points because we need to know how long after infection IL-10 
production is at it’s highest. These data points should give us a nice curve of IL-10 
production.  
 
**Because of collecting so many time points, we have decided to only focus on the 
live C. pseudotuberculosis bacteria. Otherwise, we would have changed too many 
variables at one time. 
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APPENDIX E 
 
 
Heat kill C. psTB SOP 
 
 
 
Prepared by: Amy Fish  Date:  9/6/14  
 
Reviewed by: Ann Bryant  Date: 9/6/14  
 
Approved by: Anne Lichtenwalner Date: 9/6/14  
 
The colored ink stamp indicates this is a controlled document. Absence of color 
indicates this copy is not controlled and will not receive revision updates. 
Purpose: 
This technique will inform preparing C. psTB antigen for cell stimulation. 
Hazards: 
3. Use caution, including PPE and working in BSL2 conditions (BSC), when 
handling C. psTB  
4. Always wear proper PPE 
5. All work in the lab must be done under the direct supervision of the lab technician 
or lab director. 
Specimen: 
 48 hour cultures of C. psTB (ATCC strain) 
Material Required: 
• Sterile BHI in sterile 50 ml tubes (40 ml culture) 
• Inoculating loop/stab: sterile 
• 48 hour old C. psTB culture on BAP 
• BSC 
• 2 heat blocks placed in BSC on blue mats; set to 70 and 100 C 
• 1ml pipette 
• Sterile pipette tips 
• Sterile PBS 
• 70% ethanol 
• KIM wipes 
• Microscope 
• Spectrophotometer and cuvettes 
• 1.5 ml sterile snapcap tubes; ~30 
• Timer 
• Ice bath 
Procedure: 
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14. Day 0: pick 1 colony from the 48 hour culture, inoculate each of the BHI tube 
with a group of colonies picked up by sterile loop. Grow in CO2 incubator at 37C 
15. Day 2: Place heat blocks in BSC, set temp.  Turn on spec. Label 1.5 ml tubes 
(cultures A or B, txt 1-5: 1 is RT control, 2 is 70 for 5 min, 3 is 70 for 10, 4 is 100 
for 5 min, 5 is 100 for 10 min). 
16. Pipette 1 ml of each culture into the appropriate tubes 
a. Incubate each tube in the appropriate heat block for the appropriate time.  
Immediately remove into ice when finished. 
17. Using 5 ml of culture, use Spec 20 to read T at 590 nm.  Record. 
18. Split 5 BAP, label as 1-5, then label ½ A and ½ B of each plate.  Streak each 
snapcap vial’s contents onto a ½ plate using sterile technique.   
19. Culture for 48 hours at 37C in CO2 and check for growth. 
Procedural Notes 
              
 
References: 
http://web.mnstate.edu/provost/CountingCellsHemocytometer.pdf 
http://www.lipidmaps.org/protocols/PP0000000100.pdf 
http://triangleresearchlabs.net/wp-content/uploads/downloads/2013/01/Trypan-
Blue-Cell-Counting-Protocol.pdf 
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APPENDIX F 
 
Replating macrophages SOP 
 
Prepared by: Amy Fish  Date:  10/6/14  
 
Reviewed by: Ann Bryant  Date: 10/6/14  
 
Approved by: Anne Lichtenwalner Date: 10/6/14  
 
The colored ink stamp indicates this is a controlled document. Absence of color 
indicates this copy is not controlled and will not receive revision updates. 
Purpose: 
To remove differentiated macrophages and calculate viability and concentration. 
Hazards: 
1. Exposure to penicillin and streptomycin for allergic personnel: wearing safety 
glasses, a mask, gloves and labcoat is recommended when working with this 
substance.  Working in groups of at least 2 people is required. 
2. Trypan blue may cause irritation if it comes in contact with skin. It is a known 
carcinogen. Use impervious gloves to handle and wear eye protection. 
3. Always wear proper PPE. 
4. All work in the lab must be done under the direct supervision of the lab technician 
or lab director. 
Specimen: 
• Ovine or bovine macrophages cultured in a flask or 48-well plate 
Material Required: 
• 75 ml per each 24-well plate of RPMI-1640 w/ L-glutamine (SH3002701) 
supplemented with 10% Heat Inactivated Fetal Bovine Serum (SH3091002HI) 
and Penicillin/Streptomycin (BP295950) (1000 U/mL Penicillin and 10 mg/mL 
Streptomycin) (See Cell Wash SOP for instructions on making RPMI) 
• 24-well Corning plate 
• Hank’s Balanced Salt Solution (HBSS) (SH3001602) 
• Motorized pipettor 
• 25ml sterile pipette tips 
• Inverted Microscope 
• 1 ml pipettor and sterile tips 
• 37C 5% CO2 Incubator 
Procedure: 
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Prepare the 24-well Plate 
1. Pipette 2 ml of supplemented RPMI (see Cell Wash SOP) into each of the 24 
wells  
 
Removal Step- 48-well 
1. Using a sterile 1 ml pipette tip, scrape the bottom and sides of the well to remove 
adherent macrophages 
2. Complete a cell count on the well to assess viability 
3. Using a sterile small pipette tip and a 200µl pipettor, pipet 40µl out of the well, 
and pipet the cells and media into each well on the 24-well plate.  
4. Add 2.9 ml of supplemented RPMI into each well. 
5. Check adherence under inverted scope. 
6. Place cells in 37C 5% CO2 incubator. 
Procedural Notes 
Some work done in H262; shared BSL2 compatible lab. 
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